Trial intelligence / Profile preview

Autologous Bone Marrow Stem Cells in Pediatric Dilated Cardiomyopathy

NCT02479776Completed

Sponsor
Great Ormond Street Hospital
Start
May 2008
Primary completion
Jan 2015
01

Overview

Randomised, double-blind trial of autologous bone marrow-derived mononuclear cell in dilated cardiomyopathy (DCM), sponsored by Great Ormond Street Hospital. Primary endpoint: Adverse events at 6 months. Started May 2008; status: completed.

02

Drugs

autologous bone marrow-derived mononuclear cell
03

Conditions

dilated cardiomyopathy (DCM)

Beyond the preview

Go deeper on NCT02479776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02479776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call